Personal information

Other IDs

Scopus Author ID: 55255864000
ResearcherID: N-3304-2016
Loop profile: 1020389

Countries

United States

Activities

Collapse all

Employment (5)

HDT Bio Corp.: Seattle, Washington, US

2018-04-01 to present | CSO
Employment
Source: Self-asserted source
Darrick Carter

University of Washington: Seattle, WA, US

2014-06-01 to present | Affiliate Professor (Medical Genetics)
Employment
Source: Self-asserted source
Darrick Carter

Compliment Corp.: Seattle, WA, US

2009-08-01 to present | CEO (Research)
Employment
Source: Self-asserted source
Darrick Carter

PAI Life Sciences Inc.: Seattle, WA, US

2004-04-01 to present | CEO (Research)
Employment
Source: Self-asserted source
Darrick Carter

Infectious Disease Research Institute: Seattle, WA, US

2005-01-01 to 2019-12-31 | Vice President (Adjuvants)
Employment
Source: Self-asserted source
Darrick Carter

Education and qualifications (2)

Oregon Health and Science University: Portland, OR, US

1993-10-01 to 1998-10-01 | Ph.D. (Biochemistry)
Education
Source: Self-asserted source
Darrick Carter

Oregon State University: Corvallis, OR, US

1990-10-01 to 1993-06-30 | B.S. (Biochemistry)
Education
Source: Self-asserted source
Darrick Carter

Funding (10)

Tumor Tight Junction Opener + Chemotherapy Conjugates to Treat Cancer

2014-09-23 to 2015-04-22 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 1R43CA183379-01
GRANT_NUMBER: 1R43CA183379-01
Source: Self-asserted source
Darrick Carter via DimensionsWizard

IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs

2013-09-16 to 2014-09-15 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 272201300014C-0-0-1
GRANT_NUMBER: 272201300014C-0-0-1
Source: Self-asserted source
Darrick Carter via DimensionsWizard

A Vaccine for Schistosomiasis, SchistoShield

2013-01-01 to 2018-12-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://grants.uberresearch.com/100000060/R44AI103983/A-Vaccine-for-Schistosomiasis-SchistoShield
GRANT_NUMBER: 2R44AI103983-03A1
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Process Development on a Schistosomiasis Vaccine, SchistoShield???

2013-01-01 to 2015-12-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5R43AI103983-02
GRANT_NUMBER: 5R43AI103983-02
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Reducing Complement Inhibition to Treat Leukemia and Lymphoma

2011-09-22 to 2015-07-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 5R44CA162582-03
GRANT_NUMBER: 5R44CA162582-03
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Reducing Complement Inhibition to Treat Leukemia and Lymphoma

2011-09-22 to 2012-08-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: 1R43CA162582-01
GRANT_NUMBER: 1R43CA162582-01
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Developing a new rapid test for human African trypanosomiasis

2009-03-01 to 2010-02-28 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1R43AI082800-01
GRANT_NUMBER: 1R43AI082800-01
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Developing a new leprosy diagnostic test

2007-09-01 to 2008-06-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1R43AI066613-01A1
GRANT_NUMBER: 1R43AI066613-01A1
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Developing a new leprosy diagnostic test

2005-05-01 to 2010-06-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5R44AI066613-03
GRANT_NUMBER: 5R44AI066613-03
Source: Self-asserted source
Darrick Carter via DimensionsWizard

X-RAY CRYTALLOGRAPHIC STUDY OF TOXOPLASMA GONDII HGXPRT

1998-04-01 to 1998-07-17 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1F32AI010105-01
GRANT_NUMBER: 1F32AI010105-01
Source: Self-asserted source
Darrick Carter via DimensionsWizard

Peer review (5 reviews for 1 publication/grant)

Review activity for npj vaccines. (5)
How many people are using ORCID?